Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
AAPS Pharmscitech|August 19, 2018
Using Manufacturing Design Space Concepts for Stability Risk Assessment-Gabapentin NIPTE/FDA Case StudyStephen D Stamatis, Lee E KirschMolecular Pharmaceutics|December 16, 2021
Lilly Absorption Modeling Platform: A Tool for Early Absorption AssessmentStephen D Stamatis, John P RoseAAPS Pharmscitech|August 18, 2018
Particle Size Distribution Equivalency as Novel Predictors for BioequivalencePratak Ngeacharernkul, Stephen D Stamatis, Lee E KirschJournal of Pharmaceutical Sciences|April 23, 2015
A Novel Method for Assessing Drug Degradation Product Safety Using Physiologically-Based Pharmacokinetic Models and Stochastic Risk AssessmentHoa Q Nguyen, Stephen D Stamatis, Lee E KirschThe Journal of Physical Chemistry. B|May 16, 2025
The Impact of Permeation Enhancers on Transcellular Permeation of Small Molecule DrugsMabel Bernaldez, Christopher Kang, Stephen D Stamatis, et al.The Journal of Physical Chemistry. B|January 17, 2024
Interaction between Permeation Enhancers and Lipid BilayersChristopher Kang, Mabel Bernaldez, Stephen D Stamatis, et al.Pharmaceutical Research|February 3, 2018
Polymorphic and Covalent Transformations of Gabapentin in Binary Excipient Mixtures after Milling-Induced StressRadaduen Tinmanee, Stephen D Stamatis, Eji Ueyama, et al.CPT: Pharmacometrics & Systems Pharmacology|August 22, 2025
A Combined Modeling Approach to Predict the Effect of Gastric Emptying Delay on the Pharmacokinetics of Small MoleculesMaria M Posada, Karen B Schneck, Bridget L Morse, et al.Molecular Pharmaceutics|April 29, 2025
Development of a Physiologically Based Biopharmaceutics Model Report Template: Considerations for Improved Quality in View of Regulatory SubmissionsSumit Arora, Xavier Pepin, Masoud Jamei, et al.Pageof 1